Meta Health Limited (SGX:5DX)
Singapore · Delayed Price · Currency is SGD 0.0050
0.00 (0.00%)
At close: May 19, 2026
Meta Health Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.4 | 1.36 | 0.24 | 4.61 | 11.39 | 43.03 | |
Revenue Growth (YoY) | 167.19% | 455.46% | -94.69% | -59.49% | -73.53% | 33.48% |
Cost of Revenue | 0.1 | 0.09 | 0.06 | 3.79 | 9.53 | 22.72 |
Gross Profit | 1.3 | 1.27 | 0.19 | 0.83 | 1.86 | 20.3 |
Selling, General & Admin | 1.37 | 1.41 | 0.9 | 2.75 | 3.99 | 13.1 |
Amortization of Goodwill & Intangibles | 0 | 0 | - | - | - | - |
Other Operating Expenses | 0.9 | 0.91 | -0.26 | 0.69 | 1.75 | 4.44 |
Operating Expenses | 2.34 | 2.39 | 0.65 | 3.63 | 6.63 | 20.33 |
Operating Income | -1.04 | -1.12 | -0.46 | -2.81 | -4.78 | -0.03 |
Interest Expense | -0.16 | -0.13 | -0.14 | -0.29 | -0.27 | -0.5 |
Interest & Investment Income | 0 | 0 | 0.01 | 0 | 0 | 0.03 |
Currency Exchange Gain (Loss) | -0 | -0 | 0.01 | -0.04 | -0.39 | -0.37 |
Other Non Operating Income (Expenses) | 0 | 0 | 0.02 | -0.01 | -0.54 | - |
EBT Excluding Unusual Items | -1.2 | -1.26 | -0.57 | -3.15 | -5.97 | -0.87 |
Impairment of Goodwill | - | - | -0.4 | -0.1 | - | -7.05 |
Gain (Loss) on Sale of Assets | - | - | -0 | -0.08 | 0 | 9.83 |
Asset Writedown | - | - | -0.08 | - | - | -0.69 |
Legal Settlements | - | - | - | - | -1.4 | - |
Pretax Income | -1.2 | -1.26 | -1.05 | -3.33 | -7.37 | 1.21 |
Income Tax Expense | -0.01 | -0.01 | -0 | - | - | -0 |
Earnings From Continuing Operations | -1.2 | -1.25 | -1.05 | -3.33 | -7.37 | 1.21 |
Earnings From Discontinued Operations | - | - | -0.4 | -5.01 | -1.34 | - |
Net Income to Company | -1.2 | -1.25 | -1.45 | -8.34 | -8.71 | 1.21 |
Minority Interest in Earnings | -0 | 0 | 0.01 | -0.07 | 0.05 | -0.05 |
Net Income | -1.2 | -1.25 | -1.44 | -8.41 | -8.66 | 1.16 |
Net Income to Common | -1.2 | -1.25 | -1.44 | -8.41 | -8.66 | 1.16 |
Shares Outstanding (Basic) | 1,376 | 1,309 | 1,057 | 658 | 555 | 414 |
Shares Outstanding (Diluted) | 1,376 | 1,309 | 1,057 | 658 | 555 | 419 |
Shares Change (YoY) | 31.04% | 23.82% | 60.60% | 18.55% | 32.45% | 12.01% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | 0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | 0.00 |
Free Cash Flow | -0.25 | -0.94 | -1.09 | -2.65 | -2.74 | -0.08 |
Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | -0.01 | - |
Gross Margin | 92.71% | 93.06% | 77.52% | 17.89% | 16.30% | 47.18% |
Operating Margin | -73.99% | -82.54% | -188.80% | -60.82% | -41.94% | -0.06% |
Profit Margin | -85.38% | -91.80% | -588.50% | -182.25% | -76.02% | 2.70% |
Free Cash Flow Margin | -17.45% | -69.28% | -446.35% | -57.46% | -24.07% | -0.19% |
EBITDA | -1.04 | -1.12 | -0.45 | -2.78 | -3.56 | 1.31 |
EBITDA Margin | -73.68% | -82.15% | -185.17% | -60.22% | -31.25% | 3.03% |
D&A For EBITDA | 0 | 0.01 | 0.01 | 0.03 | 1.22 | 1.33 |
EBIT | -1.04 | -1.12 | -0.46 | -2.81 | -4.78 | -0.03 |
EBIT Margin | -73.99% | -82.54% | -188.80% | -60.82% | -41.94% | -0.06% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.